START Dallas Fort Worth — Fort Worth, Texas

START Dallas Fort Worth is a clinical research site located in Fort Worth, Texas, United States 76104.

Crixeo Health Trust Score: 68/100 (FAIR). This profile has not yet been claimed by the site owner.

START Dallas Fort Worth has participated in 3 clinical trials with 3 currently active.

Therapeutic areas: Advanced Unresectable Hepatocellular Carcinoma, NSCLC Adenocarcinoma, Gastroesophageal Cancer (GC).

Sponsors: Riboscience, LLC., IDEAYA Biosciences, Bristol-Myers Squibb.

Sponsor Feasibility Report

Trust Score: 68/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for START Dallas Fort Worth?

START Dallas Fort Worth has a Crixeo Trust Score of 68/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has START Dallas Fort Worth conducted?

START Dallas Fort Worth has 3 clinical trials on record, with 3 currently active. Their work covers Advanced Unresectable Hepatocellular Carcinoma, NSCLC Adenocarcinoma, Gastroesophageal Cancer (GC).

Is START Dallas Fort Worth accredited by Crixeo Health?

START Dallas Fort Worth has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about START Dallas Fort Worth?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.